These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

308 related articles for article (PubMed ID: 26038753)

  • 1. Aspartate decarboxylase (PanD) as a new target of pyrazinamide in Mycobacterium tuberculosis.
    Shi W; Chen J; Feng J; Cui P; Zhang S; Weng X; Zhang W; Zhang Y
    Emerg Microbes Infect; 2014 Aug; 3(8):e58. PubMed ID: 26038753
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mutations in panD encoding aspartate decarboxylase are associated with pyrazinamide resistance in Mycobacterium tuberculosis.
    Zhang S; Chen J; Shi W; Liu W; Zhang W; Zhang Y
    Emerg Microbes Infect; 2013 Jun; 2(6):e34. PubMed ID: 26038471
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In Vivo-Selected Pyrazinoic Acid-Resistant Mycobacterium tuberculosis Strains Harbor Missense Mutations in the Aspartate Decarboxylase PanD and the Unfoldase ClpC1.
    Gopal P; Tasneen R; Yee M; Lanoix JP; Sarathy J; Rasic G; Li L; Dartois V; Nuermberger E; Dick T
    ACS Infect Dis; 2017 Jul; 3(7):492-501. PubMed ID: 28271875
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Investigation of pncA, rpsA and panD Gene Mutations Associated with Resistance in Pyrazinamide-Resistant Mycobacterium tuberculosis Isolates and Spoligotyping].
    Özgür D; Tezcan Ülger S; Kayar MB; Biçmen C; Aslantürk A; Ülger M; Aslan G
    Mikrobiyol Bul; 2022 Apr; 56(2):191-205. PubMed ID: 35477224
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phenotypic and genotypic characterization of pyrazinamide resistance among multidrug-resistant Mycobacterium tuberculosis clinical isolates in Hangzhou, China.
    Liu W; Chen J; Shen Y; Jin J; Wu J; Sun F; Wu Y; Xie L; Zhang Y; Zhang W
    Clin Microbiol Infect; 2018 Sep; 24(9):1016.e1-1016.e5. PubMed ID: 29288021
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Non-
    Werngren J; Alm E; Mansjö M
    J Clin Microbiol; 2017 Jun; 55(6):1920-1927. PubMed ID: 28404681
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanisms of Pyrazinamide Action and Resistance.
    Zhang Y; Shi W; Zhang W; Mitchison D
    Microbiol Spectr; 2013; 2(4):1-12. PubMed ID: 25530919
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pyrazinoic Acid Inhibits Mycobacterial Coenzyme A Biosynthesis by Binding to Aspartate Decarboxylase PanD.
    Gopal P; Nartey W; Ragunathan P; Sarathy J; Kaya F; Yee M; Setzer C; Manimekalai MSS; Dartois V; Grüber G; Dick T
    ACS Infect Dis; 2017 Nov; 3(11):807-819. PubMed ID: 28991455
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanisms of Pyrazinamide Action and Resistance.
    Zhang Y; Shi W; Zhang W; Mitchison D
    Microbiol Spectr; 2014 Aug; 2(4):MGM2-0023-2013. PubMed ID: 26104205
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structural and free energy landscape of novel mutations in ribosomal protein S1 (rpsA) associated with pyrazinamide resistance.
    Khan MT; Khan A; Rehman AU; Wang Y; Akhtar K; Malik SI; Wei DQ
    Sci Rep; 2019 May; 9(1):7482. PubMed ID: 31097767
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Emerging insight of whole genome sequencing coupled with protein structure prediction into the pyrazinamide-resistance signature of Mycobacterium tuberculosis.
    Huang CK; Yu MC; Hung CS; Lin JC
    Int J Antimicrob Agents; 2024 Apr; 63(4):107053. PubMed ID: 38081550
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mycobacterium tuberculosis isolates from Rio de Janeiro reveal unusually low correlation between pyrazinamide resistance and mutations in the pncA gene.
    Bhuju S; Fonseca Lde S; Marsico AG; de Oliveira Vieira GB; Sobral LF; Stehr M; Singh M; Saad MH
    Infect Genet Evol; 2013 Oct; 19():1-6. PubMed ID: 23770140
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of Novel Efflux Proteins Rv0191, Rv3756c, Rv3008, and Rv1667c Involved in Pyrazinamide Resistance in Mycobacterium tuberculosis.
    Zhang Y; Zhang J; Cui P; Zhang Y; Zhang W
    Antimicrob Agents Chemother; 2017 Aug; 61(8):. PubMed ID: 28584158
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reduced pyrazinamidase activity and the natural resistance of Mycobacterium kansasii to the antituberculosis drug pyrazinamide.
    Sun Z; Zhang Y
    Antimicrob Agents Chemother; 1999 Mar; 43(3):537-42. PubMed ID: 10049264
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pyrazinamide resistance among multidrug-resistant tuberculosis clinical isolates in a national referral center of China and its correlations with pncA, rpsA, and panD gene mutations.
    Gu Y; Yu X; Jiang G; Wang X; Ma Y; Li Y; Huang H
    Diagn Microbiol Infect Dis; 2016 Mar; 84(3):207-11. PubMed ID: 26775806
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pyrazinamide Resistance and Mutation Patterns Among Multidrug-Resistant
    Shi J; Su R; Zheng D; Zhu Y; Ma X; Wang S; Li H; Sun D
    Infect Drug Resist; 2020; 13():2929-2941. PubMed ID: 32903869
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Atypical Genetic Basis of Pyrazinamide Resistance in Monoresistant Mycobacterium tuberculosis.
    Modlin SJ; Marbach T; Werngren J; Mansjö M; Hoffner SE; Valafar F
    Antimicrob Agents Chemother; 2021 May; 65(6):. PubMed ID: 33722890
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structural basis for targeting the ribosomal protein S1 of Mycobacterium tuberculosis by pyrazinamide.
    Yang J; Liu Y; Bi J; Cai Q; Liao X; Li W; Guo C; Zhang Q; Lin T; Zhao Y; Wang H; Liu J; Zhang X; Lin D
    Mol Microbiol; 2015 Mar; 95(5):791-803. PubMed ID: 25430994
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structural and Mechanistic Insights into
    Saw WG; Leow CY; Harikishore A; Shin J; Cole MS; Aragaw WW; Ragunathan P; Hegde P; Aldrich CC; Dick T; Grüber G
    ACS Infect Dis; 2022 Jul; 8(7):1324-1335. PubMed ID: 35731701
    [No Abstract]   [Full Text] [Related]  

  • 20. Detection of Novel Gene Mutations Associated with Pyrazinamide Resistance in Multidrug-Resistant
    Hameed HA; Tan Y; Islam MM; Lu Z; Chhotaray C; Wang S; Liu Z; Fang C; Tan S; Yew WW; Zhong N; Liu J; Zhang T
    Infect Drug Resist; 2020; 13():217-227. PubMed ID: 32158237
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.